BOCT vs JANH
Innovator U.S. Equity Buffer ETF - October vs Innovator Premium Income 20 Barrier ETF - January
Which is better, BOCT or JANH?
BOCT has been ahead.
BOCT led over 1Y and the full window.
MarketXLS is not an investment adviser. This comparison is generated automatically from market data and is for information only. A Best mark means the better reading on that one measure, not a recommendation to buy.
Side-by-Side Comparison
| Metric | BOCT | JANH |
|---|---|---|
| Expense Ratio | 0.79%Tie | 0.79%Tie |
| AUM | $307M | $12M |
| Dividend Yield | 0.00% | 6.25% |
| Holdings | 18 | 19 |
| YTD Return | +12.12%Best | +0.85% |
| 1Y Return | +15.15%Best | +0.12% |
| 3Y Return (annualized) | +15.46% | - |
| 5Y Return (annualized) | +10.73% | - |
| Volatility (annualized) | 7.4% | 4.3%Best |
| Max Drawdown | -13.6% | -10.4%Best |
| $10,000 over 2.8 years | $14,510Best | $10,090 |
| Fund Family | Innovator ETFs Trust | Innovator ETFs Trust |
| Category | Alternative | Alternative |
| Style | Option Writing | Option Writing |
| Inception | Sep 28, 2018 | Jan 2, 2024 |
Not shown on this pair: Top 10 Weight.
Volatility and max drawdown, and the $10,000 over 2.8 years row, are measured over the window both funds cover: Jan 2, 2024 to Oct 14, 2026 (2.8 years).
BOCT vs JANH growth
Month-end closes. Both lines start at 0% in the first month shown, so the gap between them is the difference in growth across that window. The full view is available from the range buttons; it is not the opening view here because over the whole period one of these two funds moves so much further than the other that its line would sit flat on the axis.
BOCT vs JANH Performance
Innovator U.S. Equity Buffer ETF - October (BOCT) is an ETF from Innovator ETFs Trust and Innovator Premium Income 20 Barrier ETF - January (JANH) is an ETF from Innovator ETFs Trust. Over the past year BOCT returned +15.15% while JANH returned +0.12%. Year to date, BOCT is up 12.12% versus a gain of 0.85% for JANH.
Past performance does not guarantee future results.
Risk: Volatility and Drawdowns
BOCT has been the more volatile fund, with annualized monthly volatility of 7.4% compared with 4.3% for JANH. Lower volatility generally means a smoother ride, though it often comes with lower long-run returns.
The deepest peak-to-trough decline in our data was -13.6% for BOCT and -10.4% for JANH. Drawdown depth is what each fund did in the worst stretch of the window measured above.
The two funds' monthly returns correlate at 0.76. They usually move together, but the gap leaves some room for diversification.
Fees and Cost Over Time
BOCT charges 0.79% per year while JANH charges 0.79%. On a $10,000 position that is $79 vs $79 annually. On income, BOCT currently yields 0.00% against 6.25% for JANH.
You are not choosing between two funds in isolation.
Whichever of BOCT and JANH you pick has to sit alongside everything else you own. Add the rest and see what the combination actually holds.
Free for up to 10 holdings. No account needed.
Frequently Asked Questions
Which is cheaper, BOCT or JANH?
BOCT has an expense ratio of 0.79% while JANH charges 0.79%. At the precision these are quoted to, they cost the same.
Which performed better, BOCT or JANH?
Over the past year BOCT returned +15.15% vs +0.12% for JANH, so BOCT leads on 1-year performance. Past performance does not guarantee future results. This is information, not a recommendation.
Which is riskier, BOCT or JANH?
BOCT has been the more volatile fund at 7.4% annualized versus 4.3% for JANH. Worst drawdown: BOCT -13.6% vs JANH -10.4%.
Should I hold both BOCT and JANH?
BOCT and JANH have a monthly-return correlation of 0.76, so their returns are far enough apart for the mix to behave differently from either one alone. This is information, not a recommendation.
Which pays a higher dividend, BOCT or JANH?
BOCT yields 0.00% while JANH yields 6.25%, so JANH currently pays the higher dividend yield.
Is JANH better than BOCT?
BOCT led over 1Y and the full window. Which one suits a particular account depends on what it is for. This is information, not a recommendation.